Close Menu

Carl Zimmer heard Craig Venter speak at the Oxonian Society in New York. The audience, says Zimmer, was more interested in people than in Venter's energy plans, so Venter told them about the differences between his genome and James Watson's. When one person asked about the ethics of cloning and whether armies of clones would arise, Venter said that scientists don't have such science fiction-ish ambition because they're too boring.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.